| Literature DB >> 33980313 |
Perry R Fleming1,2, Makayla M Swygert2,3, Coen Hasenkamp2,3, Jessica Sterling2, Ginny Cartee2, Rebecca Russ-Sellers2,3, Melanie Cozad2,4, Renee J Chosed3, William E Roudebush3, Ann Blair Kennedy5,6,7.
Abstract
BACKGROUND: Patient and Public Involvement (PPI) in research is increasingly being utilized to better connect patients and researchers. The Patient Engagement Studio (PES) supports PPI in research by working directly with researchers throughout various stages of their projects. Recently, two researchers presented to the PES for assistance with their project, Embryo+™. The purpose of Embryo+™ is to decrease miscarriage rates using RNA sequencing technology that screens for the most viable embryos. To date, no examples of PPI directly in the planning or implementation of bench research concerning in vitro fertilization and embryo transfer have been identified. MAIN BODY: Embryo+™ researchers met in-person with the PES two times (fall 2019; each meeting had 9 PES members in attendance) for initial feedback and protocol development. After these meetings, PES leadership and Embryo+™ researchers decided that the unique nature of the project merited a PPI evaluation. Subsequent evaluation of engagement efforts occurred by reviewing the PES reports for the Embryo+™ researchers, conducting two recorded web-based discussion meetings with the PES (summer 2020; meeting 1 n = 7; meeting 2 n = 6), and a brief survey (n = 13). The discussion meetings provided an opportunity for the PES members to define engagement themes through consensus via verbal agreement to the studio director's periodic summaries during the discussions. Combining survey results and PES themes allowed for a broad discussion for meaningful engagement. The Embryo+™ researchers established trust with the patients by changing some of their language in response to patient suggestions, allowing for unintended ethical conversations, and implementing the patient developed protocols. Overall, the patient experts thought this project was very meaningful and valuable, quantified by a mean loyalty score 89.43 (s.d. 10.29).Entities:
Keywords: Fertilization in vitro; Patient participation; RNA sequence analysis; Reproductive techniques; Research personnel; Stakeholder participation; Surveys and questionnaires; Trust
Year: 2021 PMID: 33980313 PMCID: PMC8115861 DOI: 10.1186/s40900-021-00278-x
Source DB: PubMed Journal: Res Involv Engagem ISSN: 2056-7529
Fig. 1Seven step process for engaging with the Patient Engagement Studio
Patient Engagement Studio Demographics–Embryo+™ Participation
| Variable | n = 13 |
Age, mean (SD) min, max | 58 (14.08) 35,73 |
| Gender identity, n(%) | |
| Man | 3 (23.8) |
| Woman | 9 (69.23) |
| Transgender woman | 1 (7.69) |
| Race/Ethnicity, n (%) (% of cases) | |
| Black or African American | 2 (15.38) |
| White | 10 (76.92) |
| Choose not to answer | 1 (7.69) |
| Hispanic/Latino/a/x | 0 (0) |
Patient Engagement Studio Role, n (%) (may check more than one role) | |
| Patient Expert | 11 (61.11) |
| Community member | 1 (5.56) |
| Clinician | 1 (5.56) |
| Staff member | 1 (5.56) |
| Researcher | 4 (22.22%) |
| Meeting attendance, n | |
| Embryo+™ meeting 1 (project introduction) | 9 |
| Embryo+™ meeting 2 (selecting donors) | 9 |
| Discussion about meeting 1 | 7 |
| Discussion about meeting 2 | 6 |
Fig. 2Final process for filtering donors. PESMs determined that first race/ethnicity would be selected, then O- blood type, CMV negative, donor openness to contact in the future by the resultant child, and finally the fewest checks in health history and/or genetic abnormalities. If more than one donor was left, then the researcher would choose the final donor